153 related articles for article (PubMed ID: 36052238)
21. Conversion surgery for an initially unresectable, locally advanced pancreatic cancer after induction chemotherapy and carbon-ion radiotherapy: a case report.
Fujishiro T; Mashiko T; Masuoka Y; Yamada M; Furukawa D; Yazawa N; Kawashima Y; Ogawa M; Hirabayashi K; Nakagohri T
Surg Case Rep; 2018 Sep; 4(1):112. PubMed ID: 30203372
[TBL] [Abstract][Full Text] [Related]
22. Who benefits from R0 resection? A single-center analysis of patients with stage Ⅳ gallbladder cancer.
Chen C; Wang L; Zhang R; Li Q; Zhao YL; Zhang GJ; Li WZ; Geng ZM
Chronic Dis Transl Med; 2019 Sep; 5(3):188-196. PubMed ID: 31891130
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of paclitaxel and S-1 combined with apatinib in the conversion therapy for unresectable advanced gastric cancer.
Wu Z; Fang H
J BUON; 2021; 26(4):1485-1490. PubMed ID: 34565008
[TBL] [Abstract][Full Text] [Related]
24. Conversion surgery for initially unresectable advanced biliary tract cancer treated with gemcitabine plus cisplatin combination chemotherapy: a case report and literature review.
Miyamoto R; Ogura T; Takahashi A; Ishida H; Matsudaira S; Amikura K; Suzuki Y; Shimizu S; Kihara A; Kanda H; Kawashima Y
Int Cancer Conf J; 2022 Jul; 11(3):188-195. PubMed ID: 35669899
[TBL] [Abstract][Full Text] [Related]
25. Successful conversion surgery of distal pancreatectomy with celiac axis resection (DP-CAR) with double arterial reconstruction using saphenous vein grafting for locally advanced pancreatic cancer: a case report.
Murase Y; Ban D; Maekawa A; Watanabe S; Ishikawa Y; Akahoshi K; Ogawa K; Ono H; Kudo A; Kudo T; Tanaka S; Tanabe M
Surg Case Rep; 2020 Dec; 6(1):302. PubMed ID: 33259017
[TBL] [Abstract][Full Text] [Related]
26. Safety and Efficacy of Modified FOLFIRINOX in Unresectable or Metastatic Gallbladder Cancer: A Phase II Pilot Study.
Sharma A; Pramanik R; Kumar A; Pathy S; Kumar S; Bhoriwal S; Thulkar S; Dash NR; Pal S; Choudhary P; Pawar S; Kumar R; Gupta G
JCO Glob Oncol; 2021 Jun; 7():820-826. PubMed ID: 34086477
[TBL] [Abstract][Full Text] [Related]
27. Successful conversion surgery for unresectable pancreatic cancer with peritoneal metastases after neoadjuvant albumin-bound paclitaxel and gemcitabine chemotherapy: case report and literature review.
Kobayashi Y; Maeda S; Hama N; Miyamoto A; Uemura M; Miyake M; Nishikawa K; Hirao M; Kato T; Sekimoto M; Mori K; Mano M; Nakamori S
Int Cancer Conf J; 2018 Jan; 7(1):20-25. PubMed ID: 31149507
[TBL] [Abstract][Full Text] [Related]
28. [Three Cases of Conversion Surgery for Unresectable Advanced Gallbladder Cancer with Distant Metastasis Treated with Gemcitabine plus CDDP].
Urata F; Akaishi T; Uchida C; Jin H; Nakai M; Kato M; Kawashima H; Toyoki Y
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1792-1794. PubMed ID: 38303209
[TBL] [Abstract][Full Text] [Related]
29. Modified FOLFIRINOX for unresectable locally advanced or metastatic gallbladder cancer, a comparison with GEMOX regimen.
Cui XY; Li XC; Cui JJ; Wu XS; Zou L; Song XL; Ren T; Zhu YD; Li HF; Yang Y; Liu K; Han XS; Jia ZY; Wu WG; Wang XA; Gong W; Wang LW; Li ML; Liu YB
Hepatobiliary Surg Nutr; 2021 Aug; 10(4):498-506. PubMed ID: 34430528
[TBL] [Abstract][Full Text] [Related]
30. [Clinical significance and efficacy of conversion surgery for patients with stage IV gastric cancer].
Zhu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1087-1092. PubMed ID: 30370504
[TBL] [Abstract][Full Text] [Related]
31. Case Report: Durable Complete Response After Combined Immunotherapy Following Resection of Primary Tumor in a Gallbladder Cancer Patient With Distant Metastatic Lymph Nodes of Favorable Immune-Microenvironment.
Yi B; Zhao Z; Dong H; Yuan L; Wu Y; Xu Y; Jiang X; Sun C; Wu D; Xiao Y
Front Immunol; 2022; 13():820566. PubMed ID: 35242133
[TBL] [Abstract][Full Text] [Related]
32. Long-term survival after multidisciplinary therapy for residual gallbladder cancer with peritoneal dissemination: a case report.
Kuga D; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
Surg Case Rep; 2017 Dec; 3(1):76. PubMed ID: 28616794
[TBL] [Abstract][Full Text] [Related]
33. Analysis of wedge resection of gallbladder bed and lymphadenectomy on adequate oncologic clearance for gallbladder cancer.
Tewari M; Kumar S; Shukla S; Shukla HS
Indian J Cancer; 2016; 53(4):552-557. PubMed ID: 28485349
[TBL] [Abstract][Full Text] [Related]
34. The role of staging laparoscopy in primary gall bladder cancer--an analysis of 409 patients: a prospective study to evaluate the role of staging laparoscopy in the management of gallbladder cancer.
Agarwal AK; Kalayarasan R; Javed A; Gupta N; Nag HH
Ann Surg; 2013 Aug; 258(2):318-23. PubMed ID: 23059504
[TBL] [Abstract][Full Text] [Related]
35. Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Schmid P; Rugo HS; Adams S; Schneeweiss A; Barrios CH; Iwata H; Diéras V; Henschel V; Molinero L; Chui SY; Maiya V; Husain A; Winer EP; Loi S; Emens LA;
Lancet Oncol; 2020 Jan; 21(1):44-59. PubMed ID: 31786121
[TBL] [Abstract][Full Text] [Related]
36. Anlotinib plus nab-paclitaxel/gemcitabine as first-line treatment prolongs survival in patients with unresectable or metastatic pancreatic adenocarcinoma: a retrospective cohort.
Wu H; Huang N; Zhao C; Hu X; Da L; Huang W; Shen Y; Xiong F; Zhang C
Ann Transl Med; 2022 Mar; 10(6):294. PubMed ID: 35433955
[TBL] [Abstract][Full Text] [Related]
37. Hepatic arterial infusion chemotherapy combined with bevacizumab plus a PD-1 inhibitor for gallbladder cancer with hepatic oligometastasis: a real-world study.
Zhao W; Yao Z; Li J; Li W; Dou Q; Zhao X; Wu Y; Xia N
J Gastrointest Oncol; 2024 Feb; 15(1):330-345. PubMed ID: 38482216
[TBL] [Abstract][Full Text] [Related]
38. The Survival Benefit of Chemoradiotherapy following Induction Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Unresectable Locally Advanced Pancreatic Cancer.
Takada R; Ikezawa K; Daiku K; Maeda S; Abe Y; Urabe M; Kai Y; Yamai T; Fukutake N; Nakabori T; Uehara H; Ashida R; Akita H; Takahashi H; Teshima T; Ohkawa K
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572960
[TBL] [Abstract][Full Text] [Related]
39. Gallbladder Cancer: Current Multimodality Treatment Concepts and Future Directions.
Sturm N; Schuhbaur JS; Hüttner F; Perkhofer L; Ettrich TJ
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428670
[TBL] [Abstract][Full Text] [Related]
40. A phase II study of concurrent nab-paclitaxel/carboplatin combined with thoracic radiotherapy in locally advanced squamous cell lung cancer.
Wu K; Zhu L; Wang J; Pan K; Wang B; Li X; Yang S; Xu X; Zhang M; Li X; Chen X; Ma S; Xia B
J Thorac Dis; 2019 Nov; 11(11):4529-4537. PubMed ID: 31903241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]